Diseases of the Nervous System, Phase II

An Open-Label, Multicenter Study of Nasal Foralumab in NonActive Secondary Progressive Multiple Sclerosis Patients

Volunteers
Health Professionals

Ages
18 years - 75 years
Gender
Both

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Elizabeth Labarre

elizabeth.labarre@yale.edu

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Erin Longbrake, MD, PhD
Associate Professor of Neurology; Director, Clinical Research, Neuroimmunology; Director, Fellowship Program, Multiple Sclerosis & Other Inflammatory Brain Disease; Interim Academic Chief, Neuroimmunology, Neurology

Last Updated
03/24/2026
Study IRB
#2000040467